fda regulations on semaglutide Novo Nordisk Submits CagriSema for Approval | Dr. Khizer Hussain Junaidy posted the topic FDA Grants Tirzepatide a New

GLP-1s have the potential to help drive lifetime medical savings by reducing the risk for chronic conditions

No human bioavailability data exist for oral, sublingual, or transdermal routes, so claims that one route works better in people are unsupported

Though, keep in mind that the price may vary depending on the manufacturer (in addition to other factors, like location and preferred pharmacy)

Hormone therapy has been associated with a 25% to 50% reduction in fatal cardiovascular events (the leading cause of death in women), a 50% to 60% reduction in bone fractures, a 64% reduction in cognitive decline, and a 35% decreased risk of Alzheimer disease

it reflects how hormones and drug effects interact